CSL Announces Signing of a Merger Implementation Deed to Acquire Zenyth Therapeutics Limited (Zenyth)

CSL Announces Signing of a Merger Implementation Deed to Acquire Zenyth Therapeutics Limited (Zenyth)

Melbourne, Australia — 17/07/2006

CSL Limited (CSL) and Melbourne-based biotech company, Zenyth Therapeutics Limited (Zenyth), today announced a proposal under which CSL would acquire 100% of the issued shares in Zenyth. The acquisition is to be implemented by way of a scheme of arrangement between Zenyth and its shareholders (Share Scheme).

Download the full release: PDF icon CSL Announces Signing of a Merger Implementation Deed to Acquire Zenyth Therapeutics Limited (Zenyth)

For further details contact:

Investors:
Mark Dehring 
Head, Investor Relations
+613 9389 2818
© 2016 CSL Limited